A detailed history of Wallace Advisory Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wallace Advisory Group, LLC holds 15,512 shares of PFE stock, worth $425,959. This represents 0.32% of its overall portfolio holdings.

Number of Shares
15,512
Previous 15,512 -0.0%
Holding current value
$425,959
Previous $434 Million -0.0%
% of portfolio
0.32%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $391,833 - $459,155
15,512 New
15,512 $434 Million
Q4 2023

Jan 08, 2024

BUY
$26.13 - $33.94 $63,365 - $82,304
2,425 Added 25.36%
11,986 $398 Million
Q3 2023

Oct 05, 2023

BUY
$32.09 - $37.51 $26,730 - $31,245
833 Added 9.54%
9,561 $351 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $20,522 - $26,716
521 Added 6.35%
8,728 $356 Million
Q4 2022

Feb 21, 2023

BUY
$41.75 - $54.5 $342,642 - $447,281
8,207 New
8,207 $421 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wallace Advisory Group, LLC Portfolio

Follow Wallace Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wallace Advisory Group, LLC with notifications on news.